Literature DB >> 20349235

Monoarticular septic arthritis in a patient with juvenile rheumatoid arthritis under etanercept treatment.

Kai-Cheng Lin1, Chi-Di Liang, Kuender D Yang, Hong-Ren Yu, Ho-Chang Kuo.   

Abstract

A 7-year-old girl with polyarticular type juvenile rheumatoid arthritis (JRA) presented with acute onset of right hip pain with limited range of motion and fever within the past two days. She had received etanercept for more than one year. Percutaneous arthrocentesis was performed and showed a white blood cell count of 84150/μL in the synovial fluid, although the culture showed negative results. The fever and right hip pain completely resolved after antibiotic treatment. Herein, we report the first case of septic monoarthritis of JRA under etanercept treatment.

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20349235     DOI： 10.1007/s00296-010-1459-5

Source DB:  PubMed          Journal:  Rheumatol Int        ISSN： 0172-8172            Impact factor:   2.631


  9 in total

1.  Building towards a consensus for the use of tumour necrosis factor blocking agents.

Authors:  D E Furst; F C Breedveld; J R Kalden; J S Smolen
Journal:  Ann Rheum Dis       Date:  1999-12       Impact factor: 19.103

Review 2.  Access to disease modifying treatments for rheumatoid arthritis patients.

Authors:  D E Furst; F C Breedveld; G R Burmester; L Crofford; P Emery; M Feldman; J R Kalden; A Kavanaugh; E Keystone; P E Lipsky; R N Maini; L Moreland; J S Smolen; L Van De Putte; T Vischer; M Weinblatt; M Weissman
Journal:  Ann Rheum Dis       Date:  1999-11       Impact factor: 19.103

Review 3.  Infections in systemic lupus erythematosus and rheumatoid arthritis.

Authors:  E Bouza; J G Moya; P Muñoz
Journal:  Infect Dis Clin North Am       Date:  2001-06       Impact factor: 5.982

4.  Multifocal septic arthritis and osteomyelitis caused by group A Streptococcus in a patient receiving immunomodulating therapy with etanercept.

Authors:  Robert L Elwood; Mary M Pelszynski; Larry I Corman
Journal:  Pediatr Infect Dis J       Date:  2003-03       Impact factor: 2.129

5.  Recapitulation of the round-table discussion--assessing the role of anti-tumour necrosis factor therapy in the treatment of rheumatoid arthritis.

Authors:  D E Furst; E Keystone; R N Maini; J S Smolen
Journal:  Rheumatology (Oxford)       Date:  1999-11       Impact factor: 7.580

Review 6.  Does this adult patient have septic arthritis?

Authors:  Mary E Margaretten; Jeffrey Kohlwes; Dan Moore; Stephen Bent
Journal:  JAMA       Date:  2007-04-04       Impact factor: 56.272

7.  Comparison of the characteristics of culture-negative versus culture-positive septic arthritis in children.

Authors:  Wei-Szu Chang; Nan-Chang Chiu; Hsin Chi; Wen-Chen Li; Fu-Yuan Huang
Journal:  J Microbiol Immunol Infect       Date:  2005-06       Impact factor: 4.399

8.  Risk of serious bacterial infections among rheumatoid arthritis patients exposed to tumor necrosis factor alpha antagonists.

Authors:  Jeffrey R Curtis; Nivedita Patkar; Aiyuan Xie; Carolyn Martin; Jeroan J Allison; Michael Saag; Deborah Shatin; Kenneth G Saag
Journal:  Arthritis Rheum       Date:  2007-04

9.  Safety and efficacy of up to eight years of continuous etanercept therapy in patients with juvenile rheumatoid arthritis.

Authors:  Daniel J Lovell; Andreas Reiff; Norman T Ilowite; Carol A Wallace; Yun Chon; Shao-Lee Lin; Scott W Baumgartner; Edward H Giannini
Journal:  Arthritis Rheum       Date:  2008-05
  9 in total
  1 in total

1.  Successful treatment in a child with enthesitis-related arthritis involving the sternoclavicular joint: a case report.

Authors:  Po-Yu Huang; Ling-Sai Chang; Mindy Ming-Huey Guo; Ho-Chang Kuo
Journal:  BMC Pediatr       Date:  2019-10-23       Impact factor: 2.125
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.